AB0446 Additive Inhibition of Interferons, B and T Cell Activation and TFH-Related Cytokine Cxcl13 by Leflunomide and Hydroxychloroquine Supports Rationale for Combination Therapy in PSS Patients

doi 10.1136/annrheumdis-2017-eular.5022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Ribavirin and IFN-α Combination Therapy Induces CD4+ T-Cell Proliferation and Th1 Cytokine Secretion in Patients With Chronic Hepatitis B

World Journal of Gastroenterology
MedicineGastroenterology
2007English

TFH Cell Differentiation: Missing Stat3 Uncovers Interferons’ Interference

Immunity
Infectious DiseasesAllergyImmunology
2014English

Pathogenetic Rationale for Combination Therapy of Patients With Chronic Pancreatitis

Almanac of Clinical Medicine
2016English

Alterations of T Cell Activation Signalling and Cytokine Production by Postmenopausal Estrogen Levels

Immunity and Ageing
AgingImmunology
2009English

Combination Leflunomide and Methotrexate Impedes the Recovery of Liver Fibrosis, Partly Through Inhibition of Myeloid Cell Admittance

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Rationale and Options for Combination Therapy in the Treatment of Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

GFP Affects Human T Cell Activation and Cytokine Production Following in Vitro Stimulation

PLoS ONE
Multidisciplinary
2013English

CD4+ T Cell Activation and Tolerance Induction in B Cell Knockout Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
1996English

Treatment of Spontaneous EAE by Laquinimod Reduces Tfh, B Cell Aggregates, and Disease Progression

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy